STERIS plc
corporate_fare Company Profile
STERIS plc (NYSE:STE) is a publicly traded company in the Unknown sector. Wiseek has independently scored 13 items for STE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for STE spans 424B5, 8-K, 10-Q, 10-K.
Recent high-impact activity:
- STERIS Irish FinCo Launches Two-Series Senior Notes to Fund $2.1B Xodus Deal
- STERIS Signs $1.6B Revolver and $500M Xodus-Contingent Term Loan
- Steris Guides FY Adjusted EPS to $11.35-$11.55
- STERIS Beats on Q2, Lifts FY27 EPS Outlook to $11.35-$11.55
- STERIS to Acquire Xodus Medical, Expanding Surgical Safety Portfolio
Financial Snapshot
Short Interest & Short Volume
3.56 days to coverFINRA reported short interest of 2,397,345 shares in STE as of the October 15, 2026 settlement, a 16.1% decrease from the prior period — about 3.6 days to cover at its recent average daily volume. On November 5, 2026, 61.5% of STE volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for STE, detected from its recent SEC filings.
New Automatic Shelf Registration Filed · Registration Fee Deferred
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →